Webinars
MDoutlook® Delivers Precision Intelligence
Upcoming Webinar:
Unlocking the Power of Pulse Research
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
November 18, 2021
Previous Webinars:
No post found
ThoughtLeaders in healthcare are individuals who are recognized as experts in their field. They are often thought of as innovators and visionaries, and their insights and perspectives can be highly influential in shaping the direction of the healthcare industry. As such, they can play a significant role in shaping healthcare
Read more
Would you like timely critical insights that enhance your businesses in a competitive marketplace? We’ve engaged 87,000 physicians worldwide in our active community of validated and active treaters that includes valuable Medical Key Opinion Leaders and ThoughtLeaders.
Read more
Immediate Access to Your Target Healthcare ThoughtLeaders It can be a lengthy and challenging process to identify the right healthcare ThoughtLeaders to serve as advocates for pharmaceutical brands. At MDOutlook, we make it easy to identify, engage and deploy Healthcare ThoughtLeaders who can drive value for companies. Our precision engagement
Read more
Measuring the impact of data announcements is of importance, tracking follow-up activity from a conference is of even greater importance and should not be overlooked when assessing the overall influence and reach of your messages. Having helped numerous biopharmaceutical companies track impact from their messaging activities, our experienced team shares
Read more
Oncology conferences such as American Society of Clinical Oncology (ASCO) and American Society of Hematology (ASH) are critically important industry resources that create valuable opportunities to conduct oncology market research so that more life-saving cancer treatments can reach the patients who need them. The European Society for Medical Oncology, or
Read more
Cabazitaxel was presented as an option for men with metastatic castration-resistant prostate cancer (mCRPC) who have progressed after treatment with docetaxel and an androgen signaling-targeted agent according to data presented at ESMO 2019. The results showed a significant survival benefit for Cabazitaxel in third line over enzalutamide or abiraterone where
Read more
MDOutlook empowers confident business decisions with valuable precision insights and actionable intelligence. At the recent 2019 annual meeting of the Association of Residents in Radiation Oncology (ASTRO), one of our clients was interested in recruiting very specific radiation oncologists (recruited to a very tight inclusion criteria) to an event at
Read more
ImmunoOncology (IO) expands the treatment possibilities and provides substantial clinical benefit, especially in patients who had little to no effective treatment options less than a decade ago. IO features prominently at the 2019 annual European Society for Medical Oncology (ESMO) annual congress in Barcelona where agenda items will cover topics
Read more
In today’s climate, the imperative for new products or brands to achieve their full potential quickly has never been greater. Key to achieving success is measuring and communicating progress, both internally and externally. Tracking your product is an iterative process of measuring, managing and monitoring key performance indicators (KPIs) for
Read more
Increasingly, biopharmaceutical companies recognize the importance and value of identifying and engaging ‘rising stars’ since they are typically younger, tech-engaged, offer novel perspectives, future ThoughtLeaders and a window to tomorrow’s healthcare market. Similarly, clients are increasingly using MDOutlook precision intelligence to identify the most relevant rising star ThoughtLeaders (TL; also
Read more
Archives
[archives type=monthly limit=10]
Links
FDA Drug information:
http://www.fda.gov/Drugs
European Medicines Agency:
http://www.ema.europa.eu/
Publication Research:
http://www.ncbi.nlm.nih.gov/pubmed
Clinical Trials Research:
http://www.clinicaltrials.gov/